These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2516646)

  • 1. [Will Japanese white blood be coursing through our veins? A revolution: the first synthetic blood will soon be commercialized].
    Lecuyer G
    Servir; 1989; 37(5):270-3. PubMed ID: 2516646
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood substitutes: where do we stand with the fluorocarbon approach?
    Riess JG
    Curr Surg; 1988; 45(5):365-70. PubMed ID: 3073041
    [No Abstract]   [Full Text] [Related]  

  • 3. Current perspectives on blood substitutes.
    Gould SA; Moss G
    Curr Surg; 1987; 44(4):279-81. PubMed ID: 3665573
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood substitutes as therapy in massive surgery and trauma.
    Tye RW
    Prog Clin Biol Res; 1982; 108():79-89. PubMed ID: 6817339
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of blood substitutes].
    Ohyanagi H; Saitoh Y; Mitsuno T
    Nihon Rinsho; 1980; 38(4):1966-79. PubMed ID: 6447815
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of perfluorochemicals in the treatment of acute cerebral ischemia.
    Peerless SJ
    Prog Clin Biol Res; 1983; 122():353-62. PubMed ID: 6410404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience of hemodilution with fluosol-DA (author's transl)].
    Fukushima K; Nakamura M; Takemura R
    Masui; 1981 Jul; 30(7):741-5. PubMed ID: 7321165
    [No Abstract]   [Full Text] [Related]  

  • 8. Normothermic whole body rinse-out utilizing perfluorochemical(PFC)-containing artificial blood.
    Agishi T; Yamagata K; Kobayashi M; Teraoka S; Honda H; Ota K
    Trans Am Soc Artif Intern Organs; 1984; 30():295-7. PubMed ID: 6533899
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluosol-DA as a red-cell substitute in acute anemia.
    N Engl J Med; 1986 Dec; 315(26):1677-8. PubMed ID: 3785341
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale for the clinical studies of anemia treated with the perfluorochemical emulsion: Fluosol DA 20%.
    Tremper KK
    Prog Clin Biol Res; 1983; 122():307-13. PubMed ID: 6348785
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with Fluosol-DA.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen transport in vivo by means of perfluorochemical preparations.
    Geyer RP
    N Engl J Med; 1982 Jul; 307(5):304-5. PubMed ID: 6806660
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fluorocarbons as possible oxygen-carrying blood substitutes].
    Afonin NI; Doronina NN
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):41-5. PubMed ID: 7220520
    [No Abstract]   [Full Text] [Related]  

  • 14. Present trends in fluorocarbon-based blood substitutes.
    Riess JG
    Life Support Syst; 1984; 2(4):273-6. PubMed ID: 6527557
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthetic blood: a future alternative.
    Leser DR
    Am J Nurs; 1982 Mar; 82(3):452-5. PubMed ID: 6917693
    [No Abstract]   [Full Text] [Related]  

  • 16. [The corrective effect of perfluorocarbon emulsions on the cerebral hemodynamics in craniocerebral trauma].
    Krivoshapkin AL; Krivoshapkin AL; Semenycheva TV
    Zh Vopr Neirokhir Im N N Burdenko; 1992; (6):17-9. PubMed ID: 1337408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxygen supply of the body during the administration organofluorine emulsions (a pathophysiological analysis)].
    Iarochkin VS; Koziner VB
    Patol Fiziol Eksp Ter; 1988; (3):81-6. PubMed ID: 3050820
    [No Abstract]   [Full Text] [Related]  

  • 18. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?
    Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434
    [No Abstract]   [Full Text] [Related]  

  • 19. Perfluorochemicals: artificial blood.
    Smith S
    Dimens Crit Care Nurs; 1984; 3(4):198-206. PubMed ID: 6563996
    [No Abstract]   [Full Text] [Related]  

  • 20. Success in the radical resection of esophageal cancer with artificial blood infusion: case report.
    Mitsuno T; Kawa Y; Kita A; Kohno N
    Int Surg; 1981; 66(4):355-8. PubMed ID: 7345051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.